- Motley Fool•8 hours ago
The FDA has approved Dupixent for moderate to severe eczema, and it has accepted the company's resubmission of sarilumab for rheumatoid arthritis. These drugs could give shares the shot in the arm they need.
- Zacks•22 hours ago
Regeneron Pharmaceuticals, Inc. (REGN) is scheduled to release first-quarter 2017 results on May 4, before the opening bell.
- The Wall Street Journal•yesterday
French drugmaker Sanofi said 1Q net profit jumped to about $6.2 billion, boosted by the sale of its animal-health business. To revive growth, Sanofi has boosted its research and is seeking to acquire an ...
SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||46.40 x 200|
|Ask||47.87 x 200|
|Day's Range||46.90 - 47.52|
|52 Week Range||36.81 - 47.52|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||24.31|
|Dividend & Yield||1.58 (3.40%)|
|1y Target Est||N/A|